Vimentin: the conundrum of the intermediate filament gene family

scientific article published on January 1998

Vimentin: the conundrum of the intermediate filament gene family is …
instance of (P31):
scholarly articleQ13442814
review articleQ7318358

External links are
P356DOI10.1002/(SICI)1521-1878(199801)20:1<79::AID-BIES11>3.3.CO;2-I
P8608Fatcat IDrelease_nbt4qtz7bjgmxpdbshtjqolx24
P698PubMed publication ID9504050

P2093author name stringEvans RM
P433issue1
P407language of work or nameEnglishQ1860
P304page(s)79-86
P577publication date1998-01-01
P1433published inBioEssaysQ4914614
P1476titleVimentin: the conundrum of the intermediate filament gene family
P478volume20

Reverse relations

cites work (P2860)
Q40300855A genetic strategy to overcome the senescence of primary meningioma cell cultures
Q38285932A novel role of vimentin filaments: binding and stabilization of collagen mRNAs
Q36049841Ablation of vimentin results in defective steroidogenesis
Q64890703An Interaction Network of the Human SEPT9 Established by Quantitative Mass Spectrometry.
Q40081963Bovine caruncular epithelial cell line (BCEC-1) isolated from the placenta forms a functional epithelial barrier in a polarised cell culture model
Q35918764Calpain-mediated vimentin cleavage occurs upstream of MT1-MMP membrane translocation to facilitate endothelial sprout initiation
Q30984590Confocal microscopic evidence of decreased alpha-actin expression within rabbit cerebral artery smooth muscle cells after subarachnoid haemorrhage
Q36218232Cowpea mosaic virus nanoparticles target surface vimentin on cancer cells
Q37437672Downregulation of HSP60 disrupts mitochondrial proteostasis to promote tumorigenesis and progression in clear cell renal cell carcinoma
Q37564586Downregulation of vimentin expression increased drug resistance in ovarian cancer cells
Q75322267Expression of intermediate filaments of podocytes within nephrotic syndrome glomerulopathies in children
Q37255246Fibroblast-myocyte coupling in the heart: Potential relevance for therapeutic interventions
Q90643405Filaments and phenotypes: cellular roles and orphan effects associated with mutations in cytoplasmic intermediate filament proteins
Q36944507Functional analysis of the human papillomavirus type 16 E1=E4 protein provides a mechanism for in vivo and in vitro keratin filament reorganization.
Q39810943Identification of a novel vimentin promoter and mRNA isoform
Q27321346Lipid droplets, perilipins and cytokeratins--unravelled liaisons in epithelium-derived cells
Q90101124Low-Level Laser Therapy Prevents Treadmill Exercise-Induced Progression of Arthrogenic Joint Contracture Via Attenuation of Inflammation and Fibrosis in Remobilized Rat Knees
Q36518963Murine colitis is mediated by vimentin
Q37734270Myocardial fibroblast-matrix interactions and potential therapeutic targets
Q26827684RNA protein interactions governing expression of the most abundant protein in human body, type I collagen
Q34829230Role of the cytoskeleton in formation and maintenance of angiogenic sprouts
Q33943560Taste cell function. Structural and biochemical implications
Q46370066The cytoskeleton meets the skeleton. Focus on "Deficiency of the intermediate filament synemin reduces bone mass in vivo".
Q37527096The endothelial cell-specific antibody PAL-E identifies a secreted form of vimentin in the blood vasculature
Q34389714The expression and secretion of vimentin in the progression of non-alcoholic steatohepatitis
Q58702541Vimentin Diversity in Health and Disease
Q35182104Vimentin in cancer and its potential as a molecular target for cancer therapy
Q34168677Viral nanoparticles as platforms for next-generation therapeutics and imaging devices